The Center for Biologics Evaluation and Research (CBER) is the FDA division responsible for regulating vaccines, gene therapies, blood products, and cellular therapies.
CBER reviews clinical data, manufacturing processes, and safety reporting for biologic products. Its regulatory standards shape trial design and approval pathways. CBER oversight ensures biologics meet safety and efficacy requirements.